Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies; so EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding Researchers from EPFL and the AN Bach Institute in Moscow have discovered a new and extremely promising ... (more)
http://ift.tt/PsSTzw
http://ift.tt/PsSTzw
No comments:
Post a Comment